Welcome to DukeChildrens.org.
Skip over navigation


Glycogen Storage Disease Clinical and Research Program


Dedicated to the holistic, bench-to-bedside approach to diagnosis, management, and treatment of Glycogen Storage Diseases, specializing in all types of Glycogen Storage Disease.


gsd_clinic.jpgWhat is Glycogen Storage Disease? 
Glycogen Storage Diseases (GSD) are a group of inherited disorders of metabolism that result in storage of excess glycogen (a form of stored energy for the body) caused by the lack of a particular enzyme needed for releasing glucose (a form of sugar) from glycogen. Glucose is sugar that the body uses for energy. After eating, extra glucose that is not used for energy is stored by the body as glycogen. In periods when the body needs additional energy, typically between eating and during exercise, glucose is released from stored glycogen with the help of certain enzymes. Glycogen is mainly stored in the liver and muscle. Thus, the majority of glycogen storage diseases result in excess glycogen stored primarily in the liver and/or muscles. Because the body is unable to breakdown glycogen when needed, another feature of some types of GSDs, particularly GSDs that mainly affect the liver (such as GSD I, III, VI and IX), can be periods of low blood sugar (hypoglycemia) during fasting.

Muscle symptoms associated with excess stored glycogen occur in various types of GSD, and symptoms are variable. We are learning more about muscle involvement with GSD III and IX. GSD II (Pompe disease) is not typically associated with hypoglycemia, as symptoms primarily affect the muscle. For more information about GSD II and the treatment that was developed at Duke, please visit the Pompe Disease Clinical and Research Program.       


What are the different types of Glycogen Storage Disease?


How is Glycogen Storage Disease diagnosed?
gsd_child_1.jpgThe Glycogen Storage Disease Laboratory at Duke works with health care professionals to provide testing for patients both within and outside of Duke University Medical Center. For the diagnosis of Glycogen Storage Diseases I, III, VI, and IX, enzyme activity assay and analysis for glycogen content can be assessed by performing a liver biopsy. Muscle biopsy can also test for subtypes of GSD III and GSD IX. Enzyme testing is not appropriate for carrier testing. DNA testing (genetic testing) is available through common mutation testing (for mutations that are more common in certain populations) and/or gene sequencing. DNA testing is appropriate for confirmation of clinical diagnosis, a positive family history, carrier testing, and (if familial mutations are known) prenatal testing. Prenatal testing is available on CVS samples and cultured amniocytes. For information on testing that is specific to each type of GSD, please see Glycogen Storage Disease Laboratory Test Information.

Forms

Contact the Glycogen Storage Disease Laboratory for more information:

Biochemical Genetics Laboratory
Glycogen Storage Disease Laboratory
DUHS Clinical Laboratories
801 Capitola Drive, Suite 6
Durham, NC 27713
Tel: 919-549-0445
Fax: 919-549-0709


Treatments

gsd_child_2.jpgThe Duke Glycogen Storage Disease Program follows a systematic and multidisciplinary management and treatment plan for patients with GSDs. We partner with many subspecialties at Duke to give our patients a system of providers familiar with GSD and its treatment. Our physicians and staff proudly serve a broad, international patient population, providing clinical care and consultation to individuals with Glycogen Storage Disease and their attending physicians, worldwide. Treatment is individualized based on a multidisciplinary review of our patient’s symptoms, strengths/limitations, and needs.

Top of Page


 Physicians and Staff

Medical Genetics Team

NameRole
Priya S. Kishnani, MD Division Chief, Geneticist
Dwight Koeberl, MD, PhD Geneticist
Stephanie Wechsler, MD Geneticist & Cardiologist
Y.T. Chen, MD, PhD Geneticist
Anne Boney, MEd, RD, LDN Metabolic Dietician
Stephanie DeArmey, MHS, PA-C Physician Assistant
Michelle Canfield, MSN, FNP-BC Nurse Practitioner
Joanne Mackey, MSN, CPNP Nurse Practitioner
Stephanie Austin, MS Genetic Counselor
Karen Corneilussen, MS Genetic Counselor
Jennifer Goldstein, MS, PhD Genetic Counselor
Jennifer Sullivan, MS Genetic Counselor

Affiliated Subspecialties

NameRole
Mustafa R. Bashir, MD Radiologist/Abdominal Imaging
Robert Benjamin, MD Endocrinologist/Growth
Laura Case, DPT, PCS Physical Therapist
Bryan M. Clary, MD Hepatopancreatobiliary Surgeon
Donald T. Frush, MD Pediatric Radiologist
Karla Greene, PT Physical Therapist
Rajan T. Gupta, MD Radiologist/Abdominal Imaging
John Guyton, MD Endocrinologist/Lipid Management
Lisa Hobson-Webb, MD Neurologist
Andra James, MD Obstetrics/Gynecology, Hematology
Ronald Kanter, MD Cardiologist
Richard M. Kravitz, MD Pulmonologist
Robert K. Lark, MD, MS Orthopedist
Jennifer S. Li, MD Cardiologist
Evelyn Reed, MSW, LCSW Clinical Social Worker
Yul Reinstein, MD Gastroenterologist
Alastair Smith, MB, ChB Gastroenterologist/Liver Health
Edward Smith, MD Neurologist
Stephen Smith, MD, MHS Nephrologist
Gail Spiridigliozzi, PhD Psychologist
Courtney Thornburg, MD, MS Hematology
Thomas Weber, MD Endocrinologist/Bone Health

Top of Page


Clinic Hours & Locations

Lenox Baker Children's Hospital
3000 Erwin Road
Durham, NC 27705
Tel: 919-684-6669

Hours: Mondays, 8:00 am - 3:00 pm

Additional Locations

Patients may be seen in consultation by additional sub-specialties in other outpatient clinics:

Duke Children's Hospital and Health Center
2301 Erwin Road
Durham, NC 27710
Tel: 919-668-4000

Hours: Daily, 8:30 am - 5:00 pm

Top of Page


Appointments and Contact Information

To schedule a clinic appointment with our team, contact:

Sandra Durden
Tel: 919-684-0307
Fax: 919-668-0414
sandra.durden@duke.edu

Top of Page

Research

The Duke Glycogen Storage Disease team upholds a longstanding and ongoing commitment to caring for individuals with glycogen storage diseases and their families. Some past accomplishments of the team that have translated to improved medical care of GSD patients include:

  • Identifying the causative genes for GSD I and GSD III,
  • Determining tissues in which the GSD III protein is expressed, 
  • Identifying long-term complications of GSDs,
  • Establishing a GSD I dog model colony and collaborating with other institutions to further GSD I research, and
  • Characterizing the symptoms of GSD III in a dog model housed at Duke.


Through these and other translational research initiatives, we continually strive to achieve earlier diagnoses, enhance therapy and treatment methods, improve patient and family quality of life, and maximize the day-to-day abilities for individuals living with GSD. Our team coordinates several ongoing research initiatives in order to:

  • Increase medical knowledge in order to promote early diagnosis and treatment
  • Understand the natural history and progression of symptoms across the disease spectrum of various types of Glycogen Storage Diseases
  • Better understand genotype with phenotype correlations in GSD types I, III, and IX
  • Develop and establish the role of additional biomarkers (markers in blood, urine, etc) as noninvasive surveillance of disease
  • Evaluate factors involved in the hepatic adenoma formation and transformation to hepatic carcinoma in GSD I
  • Evaluate muscle and heart involvement in GSD III
  • Determine muscle, heart, liver, and other organ involvement in subtypes of GSD IX
  • Identify the specific role of nutrition in management of features of GSDs
  • Establish new and innovative treatment strategies for Glycogen Storage Diseases 

Would you like to be a part of the future of GSD research?  Visit our Clinical Research page for more information on research opportunities for Glycogen Storage Diseases, or contact:


Stephanie Austin
Genetic Counselor
919-668-1347
stephanie.austin@duke.edu